Low-Risk MDS (Myelodysplastic Syndromes) -2023 Omaha Patient and Family Hybrid Conference @AAMDSIF
Low-Risk MDS (Myelodysplastic Syndromes) -2023 Omaha Patient and Family Hybrid Conference @AAMDSIF
Uploaded June 2026 | Updated September 2026, 1 day ago
Dr. Vijaya Bhatt discusses Low-Risk MDS in accessible terminology during this session from the 2023 Omaha, NE, Patient and Family Hybrid Conference.

For more information like this, please visit aamds.org or follow the links below:
aamds.org/diseases/mds
aamds.org/webinar/living-mds-patient-panel

#mds #myelodysplasia #myelodysplasticsyndromes
Low-Risk MDS (Myelodysplastic Syndromes) -2023 Omaha Patient and Family Hybrid ConferenceCCUS and MDS - Webinar for PatientsMedical Jargon Made SimpleNon-Transplant Therapies for Bone Marrow FailureSupportive Care for Chronic GVHDAdvances In Treatment of PNHHealth-Related Quality of Life with Namrata Chandhok, MDExtravascular Hemolysis and PNH - from Dallas Patient and Family ConferenceTransplant for Aplastic Anemia, MDS, and PNH from the 2022 Buffalo Patient and Family ConferenceLiving with PNH: Talking to Your Employer About the Family and Medical Leave Act, FMLALiving with Aplastic Anemia - Elizabeth Griffiths, MD, Roswell Park Comprehensive Cancer CenterDr. Amandeep Salhotra explains Tregzi, FDA-Approved Therapy
AAMDSIF |

Low-Risk MDS (Myelodysplastic Syndromes) -2023 Omaha Patient and Family Hybrid Conference

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER